Amwell has expanded its partnership with Tyto Care, the healthcare industry’s first all-in-one modular device and examination platform for AI-powered, on-demand, remote medical exams. The two companies will introduce exclusive integrations and newly designed workflows and tools to enhance the ability for providers using the Amwell platform to examine and diagnose patients virtually. Amwell will also become a reseller of Tyto Care’s integrated devices.
By pairing the TytoHome hand-held examination device—which enables on-demand examinations of the heart, lungs, abdomen, skin, throat, ears, heart rate, and body temperature—with Amwell’s telehealth platform, providers will be able to guide patients through virtual health examinations, which will allow the provider to get insight into a patient’s health directly in a remote visit. This enriched workflow will be available to Amwell hospitals, health systems, health plans, and employer clients.
“As COVID-19 wages on and more patients and providers adopt telehealth, it’s critical that we accelerate the depth of care that can be provided in the home—to keep patients and providers safe,” said Amwell President and CO-CEO Roy Schoenberg. “Our latest integration with Tyto Care will allow providers to clinically come closer than ever before to patients during telehealth encounters, allowing them to see, interact, examine, and deliver care in ways that growingly resemble in-person care.”
Because Amwell is a resale partner of Tyto Care, the company’s clients can now purchase Tyto Care devices, bundled with the livestream integration, directly through Amwell.
Read the full press release here.